Global BPH Treatment Market to Hit $3.38 Billion by 2032

 

The global Benign Prostatic Hyperplasia (BPH) treatment market is poised for significant expansion over the next decade. According to recent market analysis, the BPH treatment market was valued at USD 1.57 billion in 2023 and is projected to reach USD 3.38 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.92% during the forecast period from 2024 to 2032.

Get Free Sample Report on Benign Prostatic Hyperplasia (BPH) Treatment Market

https://www.snsinsider.com/sample-request/5954

This robust market growth is attributed to the rising prevalence of prostate-related disorders among aging male populations, growing awareness about early diagnosis and treatment options, and the advancement of minimally invasive and pharmacological treatment modalities.

Understanding Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia, commonly referred to as an enlarged prostate, is a non-cancerous condition that affects a large percentage of men over the age of 50. It is characterized by the proliferation of prostate gland cells, which can impede the flow of urine and lead to lower urinary tract symptoms (LUTS) such as frequent urination, nocturia, weak stream, and incomplete bladder emptying.

While BPH is not life-threatening, it can severely impact quality of life if left untreated. The increasing geriatric male population worldwide has been a driving force behind the demand for effective and accessible BPH treatments.

Market Drivers

1. Aging Global Population

One of the most significant contributors to market growth is the global demographic shift toward older populations. According to the World Health Organization (WHO), by 2030, 1 in 6 people in the world will be aged 60 years or older. With BPH prevalence closely correlated with age, this trend is expected to create a sustained demand for both diagnostic and treatment solutions.

2. Rising Awareness and Early Diagnosis

Public awareness campaigns and improved access to healthcare are leading to earlier diagnosis and treatment of BPH. As men become more proactive about their health, especially concerning urological and sexual health, the market is expected to see increased uptake of medications and therapies.

3. Technological Advancements in Minimally Invasive Surgery

The market is witnessing a significant shift toward minimally invasive surgical procedures such as UroLift System, Rezum Water Vapor Therapy, and laser-based therapies. These innovations offer shorter recovery times, fewer complications, and high efficacy, making them increasingly popular over traditional surgical methods like TURP (Transurethral Resection of the Prostate).

Key Segments

By Treatment

·         Minimal Invasive Surgery

·         Invasive Surgery

By Procedure

·         Transurethral Resection of the Prostate

·         Prostate Laser Surgery

·         Transurethral Microwave Thermotherapy

·         Transurethral Needle Ablation of the Prostate

·         Prostatic Urethral Lift

·         Water Vapor Therapy

·         Robot-Assisted Laparoscopic Prostatectomy

·         Aquablation Therapy

·         Prostatic Artery Embolization

·         Open Prostatectomy

·         Bipolar Enucleation of Prostate

·         Transurethral Incision of the Prostate

·         High-Intensity Focused Ultrasound

By Product

·         Resectoscopes

·         Urology Laser

·         Radiofrequency Ablation

·         Electrodes

·         Catheters

·         Prostatic Stents

·         Implants

·         Others

By End-use

·         Hospitals

·         Specialty Facilities

·         Research and Manufacturing

 

 Key Players and Their Products in the Benign Prostatic Hyperplasia (BPH) Treatment Market

·         Karl Storz – Resectoscopes, Urology Laser Systems, Bipolar Electrodes

·         Boston Scientific Corporation – Rezūm Water Vapor Therapy, GreenLight Laser Therapy System, SpaceOAR Hydrogel

·         Olympus America – Plasma-OvalButton, UES-40 SurgMaster, THUNDERBEAT System

·         Endo Pharmaceuticals Inc. – Aveed, Xiaflex (used for urological conditions)

·         biolitec AG – Leonardo Laser Systems, LIFE Laser Therapy

·         Medifocus – Prolieve Thermodilatation System

·         Cook Medical – Resonance Ureteral Stents, Flexor Ureteral Access Sheath

·         Teleflex Incorporated – UroLift System

·         Urotronic – Optilume BPH Catheter System

·         Coloplast Corp – Titan Inflatable Penile Prosthesis (used in urology), Self-Cath Catheters

·         Richard Wolf GmbH – System green Laser, Morcellation Systems

·         PROCEPT BioRobotics Corporation – AquaBeam Robotic System (Aquablation Therapy)

 Future Outlook

With the aging male population on the rise and increasing access to both diagnosis and treatment options, the BPH treatment market is expected to see sustained and dynamic growth. The emphasis is clearly shifting toward less invasive and more effective treatments, which bodes well for innovation and patient outcomes.

Additionally, the combination of drug therapy with digital health monitoring tools is expected to open new opportunities, enabling better tracking of symptoms and improving patient adherence to prescribed treatments.

 About US

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Jagney Dave - Vice President of Client Engagement

Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)